Nasal Spray Market overall valuation is likely to surpass US$ 15 Bn by 2021

Future Market Insights (FMI) has forecast positive outlook for the nasal spray market in a recent study. The rising cases of allergic rhinitis and the demand for better accuracy in drug delivery are identified as chief growth drivers. Growth is expected to remain bullish as various countries showcase high healthcare spending.

According to a study by the Research and Development (RAND) Review blog published in 2017, nearly 60% of Americans have at least one chronic health condition, which often results in accelerating healthcare spending each year. With the incidence of chronic ailments and resultant spending on healthcare projected to spur, nasal sprays market will have positive growth on cards.

As per the report, the market’s overall valuation is likely to surpass US$ 15 Bn by 2021. Growth will continue at a positive rate, thanks to recent approvals to nasal migraine and hormonal therapies.

Among products available, nasal steroid spray will prove exceptionally lucrative, accounting for over 42% of sales in the market. Besides their improving availability, potential to offer relief from nasal allergies and  hay fever will drive growth in the category

Need More information about Report Methodology? Click here @

https://www.futuremarketinsights.com/reports/sample/rep-gb-13112

Key Takeaways from Nasal Spray Market Study   

  • Rising at above 6% CAGR between 2021 and 2031, nasal sprays market will report consistent surge in demand
  • The market in the U.S. is projected to a fast-growing one, accounting for more than 90% share in the North America market
  • Government spending on healthcare has created a conducive environment for growth in the U.K.
  • Germany will emerge as a leading market for nasal sprays sales in Europe backed by increasing healthcare spending and presence of leading manufacturers
  • Focus on health and wellness will continue rising in Japan and South Korea, driving nasal spray sales in East Asia

“Manufacturers within the nasal sprays market are focusing on expanding their geographic footprint. Consequently, strategic collaborations and acquisitions have emerged as key strategy to achieve competitive edge,” said an analyst at FMI.

Contact Sales for Further Assistance in Purchasing this Report@

https://www.futuremarketinsights.com/checkout/13112

Government Initiatives toward Nasal Spray Consumption

Governmental support for ongoing clinical research, consumption of Nasal Spray, and restricting misuse have favoured growth in demand for Nasal Spray. For instance, there has been a call for rise in production capacity of budesonide nasal spray which shortens COVID19 recovery time.

Since, nasal sprays are also used for depression patients, the market is likely to grow highly.

Who is Winning?

Nasal spray manufacturers with patented drugs are successfully allocating their distribution rights to local companies that are operational in the pain management business. This strategy provides momentum to the growth of these companies’ business, owing to strong demand for generic drugs.

For instance, In November 2019, Sandoz announced that it has entered into a binding agreement for the planned acquisition of the Japanese business of Aspen Global Incorporated (AGI), a wholly owned subsidiary of Aspen Pharmacare Holdings Limited.

About the Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here

Surface disinfectants market will register growth at 8.8% CAGR. Sales are expected to surge amid COVID-19 outbreak

Surface disinfectants are the synthetic substances that are used for cleaning and disinfecting surfaces such as counterparts, floors, and walls. They kill as well as resist microorganisms, such as fungi, viruses, and bacteria. In the last few years the sales of surface disinfectants have remarkably increased, thanks to improved awareness about the importance of proper health and hygiene. Future Market Insights (FMI) in a study has forecast the trend to continue, enabling the surface disinfectants market to surpass US$ 6.8 Bn in 2021.

The fundamental factor boosting the Surface disinfectants sales is the increasing occurrences of infections around the world. Direction from International associations such as the Center for Disease Control and Prevention (CDCP), World Health Organization (WHO), and International Federation of Infection Control (IFIC) often encourage disinfection to contain the spread of viruses, which will bode well for the market.

Need More information about Report Methodology? Click here @

https://www.futuremarketinsights.com/reports/sample/rep-gb-1177

High level disinfectants, preferably in liquid form have emerged as top-selling products in the market, which hospitals will continue as the leading end user. The demand from hospitals segment is forecast to surge at above 6.4% CAGR.

Hospitals are receiving an increasing footfall of patients, besides which focus on ensuring improved patient care and a safe environment for patients as well as healthcare providers is fuelling disinfectant demand. Besides this, the aim at preventing the risk of hospital acquired infections will continue creating sales opportunities.

Key Takeaways from Surface Disinfectants Market Study

  • Surface disinfectants market will register growth at 8.8% CAGR. Sales are expected to surge amid COVID-19 outbreak
  • The U.S. will spearhead growth in North America, accounting for maximum sales of surface disinfectants. Increasing healthcare spending will seal the dominance of the U.S.
  • Presence of a sophisticated healthcare infrastructure catapults the U.K. as a lucrative market for surface disinfectants
  • Germany and France will continue exhibiting high demand, thanks to increasing focus on health and wellness
  • Post COVID-19, sales will rise at a remarkable pace in China, Japan, and South Korea

“Rise in prevalence of hospital acquired infections (HAIs), recent COVID-19 outbreak and growing healthcare spending, will continue driving sales,” said a lead analyst at Future Market Insights.

Who is Winning?

To sustain the market, manufacturers are working towards development of innovative products that are not only suitable and required for surgeries in hospital but also for increasing the hygiene level of patients. This is because, when the patient is safe and away from HAIs he will be more co-operative throughout the procedure.

  • For an instance, in 2021, P&G launched Microban 24, the new disinfectant brand in the UK, the product range offers unrivalled protection against bacteria in homes, not only initially killing 99.9% of bacteria and select viruses, including COVID-19 virus and flu virus, but continuing to kill bacteria for up to 24 hours, even after multiple touches.
  • In 2020, Solvay launched two new products Actizone™ and Amni® Virus-Bac OFF at the forefront of innovation, which will eliminate and keep bacteria and viruses away from many surfaces and avoid cross-contamination.

Contact Sales for Further Assistance in Purchasing this Report@

https://www.futuremarketinsights.com/checkout/1177

Valuable Insights into Surface Disinfectants Market

Future Market Insights, in its new report, offers an unbiased analysis of the global surface disinfectants market, analyzing historical demand from 2016-2020 and forecast statistics for 2021-2031. The study reveals growth projections on the aerosol packaging market on the basis of product type (high-level disinfectants, low level disinfectants, and intermediate level disinfectants), material (aluminum, tin plated steel, plastic, and glass), form (liquid, gel & lotions, wipes, and sprays & foams ) and end user (hospitals, dental clinics, ambulatory surgical centers, diagnostic laboratories, reference laboratories, rehabilitation centers, long term care centers, critical care centers, pharmaceutical & biotechnology companies, and academics and research institutes) across seven regions.

Global vision screener Market sales are likely to near US$ 500 Mn by the end of 2019

Global vision screener sales are likely to near US$ 500 Mn by the end of 2019. According to a new research intelligence study presented by Future Market Insights (FMI), the market for vision screeners will continue to witness an average 5.5% Y-o-Y growth in the revenues in 2019 and ahead. As reported by the study, more than a third of overall sales of vision screeners is targeted to a variety of vision screening tests, followed by color vision tests.

While portable or handheld vision screening devices have been sought after over the years, it is more likely that the vision screening software will experience rapid gains in coming years, as a result of brisk technological penetration. Moreover, as key manufacturers are investing considerable efforts in technological innovations of vision screeners, table-top variants are also likely to see healthy sales growth in the near future. Currently, more than 50% of the total sales are accounted by portable or handheld devices that are used during vision screening procedures, as per the report.

The rising prevalence of vision problems, advancements in technology, increasing healthcare spending, and the growing prevalence of diabetes constitute some of the key factors responsible for driving the global vision screeners market revenues. In addition to some of the most commonplace vision disorders, newly establishing problems such as digital eye strain (more popularly, computer vision syndrome) are strongly necessitating the demand for efficient vision screening tests, particularly among the younger population. This, according to FMI’s analysis, will drive sales of vision screeners in the forthcoming years.

Need More information about Report Methodology? Click here @

https://www.futuremarketinsights.com/reports/sample/rep-gb-5032

Inadequate Effectiveness of Vision Screening Tests Prevails in Developing Asian Markets

Accounting for a collective value share of over 60%, North America and Europe will continue to lead the pack in global vision screeners market. In addition to early adoption of advanced technologies and high awareness about vision problems and the significance of vision screening, the growth of market in these regions has been prominently attributed to the rapid consolidation of healthcare facilities within these regions.

On the other hand, dearth of skilled and trained professionals in the field of vision screening will remain the prime factor restraining vision screeners adoption across developing Asian countries. Relatively lesser competency to professionally and accurately assess vision screening results continues to pose significant barriers in the growth path of market within Asia Pacific (APAC).

According to the report, a sizeable number of vision screening tests cannot be performed on children who have reading problems such as hyperopia or astigmatism. As a result, the ineffectiveness of vision screeners continues to negatively influence the number of parents opting for pediatric vision screening tests, which is further a significant factor deterring the revenues of vision screeners market in APAC.

Pediatric Vision Screening Emerging as a Prime Focus Area for Innovations

Some of the key players competing in the global vision screeners market landscape include Hill-Rom Holdings, Inc. (Welch Allyn), Essilor International S.A. (Stereo Optical Company Inc.), Adaptica S.r.l., OCULUS Surgical, Inc., Plusoptix Inc., Honeywell International Inc., FIM Medical SAS, SHANGHAI TOP VIEW INDUSTRIAL CO., LTD., Thomson Screening Solutions Ltd., and Keystone View. While a majority of these companies are concentrating in technological upgrades of the current offerings, augmented investments targeting FDA approvals will be an important strategy.

Contact Sales for Further Assistance in Purchasing this Report@

https://www.futuremarketinsights.com/checkout/5032

Moreover, multiple longstanding challenges prevailing in children’s vision screening are highly likely to push the scope for innovations, which would help overcome the challenges and extend the efficiency of vision screening – specifically for children. The FMI study reveals how the companies that are manufacturing, supplying, and distributing vision screeners are strategizing on the growing traction in the pediatric patients segment.

About the Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here

 

Animal Microchip Implant Market Regional Industry Segmentation, Analysis by Production, Consumption, Revenue and Growth Rate by 2027

Animal Microchip Implant Market Overview

An animal microchip implant is an innovative technology used for tracking pet animals and other healthcare issues in animals. Microchips implanted in pet animals are used to track the movement of pets to prevent the loss of pet animals. A microchip implant is a small device that can be implanted under the pet’s skin and works as an identification for that particular pet with all the pet’s information. Microchips implanted in pets have all the basic details, such as owner’s name and address and vital details with past and present medical history. Microchips have a 15-digit number, which can be scanned under a database for all the major and minor details of a pet. They provide real-time data of a pet’s locations. Two types of microchip implants are available in the market. The first, surgery-injectable implants, need be placed by veterinary surgeons and the second are available as self-implanted injectable microchips. Many tags are also available, which can be placed near the neck or other tag areas on pets. Apart from pet animals, farm animals are also implanted with microchips to monitor the activities of farm animals and track details such as vitals, health-related information and other details pertaining to the farm or the owner.

Get Free 20% customization on Pre-Booking:

https://www.futuremarketinsights.com/checkout/6881

Animal Microchip Implant Market: Drivers and Restraints

The animal microchip implant market is pegged to witness significant growth over the forecast period as pet adoptions are increasing and pet owners are becoming more aware regarding the technology. Players such as Wuxi Fofia Technology Co., Ltd, and Autag Technology Europe BV are creating a database of all animals, including pets and farm animals. Technological advancement is a major contributor to the increase in the number of animal microchip implants across the globe. On the other hand, lack of focus in veterinary health expenditure, lack of awareness regarding implant use and process to implant inside or outside the animals and others factors are expected to hinder the growth of the market.

Animal Microchip Implant Market: Overview

The animal microchip implant market is primarily driven by increasing pet adoption and awareness about animals. Animals are well managed with the help of microchip implants, which provide all the necessary details needed by animal owners. This has resulted in an increase in the number of microchip implants in animals. Other factors leading to the growth of the animal microchip implant market include the increasing number of animal management systems in farms and individual animal owners.

Animal Microchip Implant Market: Region-wise Outlook

Geographically, the animal microchip implant market can be segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, Japan, Middle East and Africa. North America is the major market for animal microchip implants as animal health expenditures in the region are relatively high as compared to other regions. Additionally, pet adoption is increasing among the population and individuals are aware of veterinary health managements with animal monitoring. Europe and Asia Pacific are growing markets for animal microchip implants as microchips help monitor and manage animals and the introduction of new veterinary technology is increasing in these regions. The MEA region is also focusing on animal management and protection.

For more insights, You can request for TOC at @ 

https://www.futuremarketinsights.com/toc/rep-gb-6881

Animal Microchip Implant Market: Key Players

Some of the players identified in the animal microchip implant market include Zee Tags Ltd, Autag Technology Europe BV, Wuxi Fofia Technology Co., Ltd, I.D.ology, Microchip Identification Systems, Inc., Pet-ID Microchips Ltd, Shenzhen ZDCARD Tech Co., LTD, Quanzhou Hecere Electronic Limited, Ningbo Luke Medical Devices Ltd,  and other Radiofrequency identification (RFID) animal microchip manufacturers.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil and Rest of Latin America)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg and Rest of Western Europe)
  • Eastern Europe (Poland, Russia and Rest of Eastern Europe)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, and Rest of MEA)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Animal Microchip Implant Market: Segmentation

The animal microchip implant market can be segmented on the basis of the following parameters:

Product type:

  • Animal ID Microchip
  • Reusable Pet Tracking Microchip
  • Transponder Microchips
  • Others

Mode:

  • Self-injectable
  • Surgery-injectable

Distribution channel:

  • Veterinary Hospitals
  • Veterinary Clinics
  • Veterinary Pharmaceutical Store
  • Online Store

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry

Cellular Pathology Market Regional Industry Segmentation, Analysis by Production, Consumption, Revenue and Growth Rate by 2027

Cellular Pathology Market: Dynamics

The Cellular pathology market is expected to mark a significant growth in the coming few years due to high probability of increase in number of cancer patient. Histopathology and cytopathology have been the main tools utilized in the diagnosis of cancer. The increased demand for pathology services is one of the major driving factor. Addition to this, government support and technological advancement are also boosting the growth of this market. However, there are some restraining factors which are restricting the growth of this market. Such as to comply with guidelines for cancer case reporting and with the various recommendations of specimen handling and additional testing, the need to improve turnaround time as a critical element in clinical management; and the need to comply with the statutory requirements of the various laboratory accreditation and quality assurance regulatory bodies.

Cellular Pathology Market: Overview

The global market for Cellular pathology market is expected to witness high growth over the forecast period. The high demand of Histopathology diagnosis due to increasing number of cancer patients. Histopathology refers to the examination of a biopsy or surgical specimen by a pathologist, in clinical medicine. The specimen has been processed and histological sections have been placed onto glass slides. This diagnosis provides the exact results of presence of disease in body. This is very necessary process to avoid error arising in the diagnostic phase, among the clinician and the pathologists.

In developed countries, scientists and health researchers are addressing the threat of cancer to humans by attempting to provide appropriate service to end users.

Get Free 20% customization on Pre-Booking:

https://www.futuremarketinsights.com/checkout/6869

Cellular Pathology Market: Key Players

The market for cellular pathology is consolidated with a presence of few strong players. CellPath Ltd is the major player operating in cellular pathology market. CellNass by CellPath Ltd., is the most trustable and adopted service in cellular pathology. The other prominent players identified in global cellular pathology market include Gilson, Inc., MilliporeSigma, Source BioScience are other major players operating in this market.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Value Chain

For more insights, You can request for TOC at @ 

https://www.futuremarketinsights.com/toc/rep-gb-6869

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
  • Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
  • Asia Pacific Excluding Japan (India, Australia & New Zealand)
  • Japan
  • China
  • The Middle East and Africa (GCC, S. Africa, Rest Of MEA)

Cellular Pathology Market: Segmentation

Tentatively, global Cellular pathology market has been segmented on the basis of product, services and geography

Based on product type, global Cellular pathology market is segmented as below

  • Equipment
  • Block Trimmers
  • Coldplates
  • Grossing / Cut Up
  • Heating Forceps & Tampers
  • Macro Digital Imaging System
  • Section Dryers & Ovens
  • Sledge Microtome
  • Slide Drying Hotplates
  • Thermometers & Probes
  • Wax Dispensers
  • Consumables

Based on services, global Cellular pathology market is segmented as below

  • Histopathology
  • Dermatopathology
  • Neuropathology
  • Non-gynaecological cytology
  • Immunohistochemistry, FISH testing and electron microscopy
  • Frozen sections

Based on end user, global Cellular pathology market is segmented as below

  • Hospitals
  • Pathology Laboratories
  • Clinical Research institutes
  • Academic Institutes

Report Highlights:

  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.

 

DNA Synthesis Market Regional Industry Segmentation, Analysis by Production, Consumption, Revenue and Growth Rate by 2027

DNA Synthesis Market: Overview

Companies involved in the DNA synthesis services market are involved in continuous updating of their manufacturing technologies for high throughput synthesis with cost control. Recently, Twist biosciences also gathered $82 million investment from Illumina for developing a new technology platform for synthesizing DNA on silicon. These market players are also focusing on their brand improvement and market penetration by focusing on their sales force, geographical expansion as well as expansion of manufacturing facilities.

Moreover, synthetic DNA costs are anticipated to decrease owing to the introduction of advanced technology.  Intensifying competition in the synthetic biology services also leads to price reduction per base pair. However, the multi-billion dollar PCR industry constantly supports the market growth of DNA synthesis services. With the increasing outsourcing services for the life science research activities, the market has huge potential of growth opportunities. The availability of research funds also had a great impact in the DNA synthesis market size and growth rate in different regions over the globe.

Get Free 20% customization on Pre-Booking:

https://www.futuremarketinsights.com/checkout/5900

DNA Synthesis Market: Region-wise Outlook

Geographically, North America leads the market for DNA synthesis services owing to the high requirement in the academic research as well as biopharmaceutical industries for research and therapeutic production. This is followed by the Western Europe region supported by the high availability of research fundings in universities and commercial availability of therapeutic drugs made of DNA active pharmaceutical ingredients. Eastern Europe region shares a low market share and slow growth rate comparatively to other regions over the forecast period. Asia Pacific region represents the significant growth rate in the DNA synthesis market with highest market growth in research applications. Recent trends shows China to be leading the market in the region in terms of market size as well as growth rate. Latin America and Middle East & Africa has been observed the least market share over the forecast period.

DNA Synthesis Market Treatment Market: Key Players

Some of the players in the DNA Synthesis market includes Bioneer Corporation, IBA GmbH, Eurofins Scientific, Integrated DNA Technologies, Inc., LGC Biosearch Technologies, Eton Bioscience, Inc., GenScript Biotech Corporation, Eurogentec, Thermo Fisher Scientific, Inc., Quintara Biosciences and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

For more insights, You can request for TOC at @ 

https://www.futuremarketinsights.com/toc/rep-gb-5900

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

DNA Synthesis Market: Segmentation

Segmentation by Service Type:

  • Oligonucleotide Synthesis
  • Universal Oligonucleotide Synthesis
  • Custom Oligonucleotide Synthesis
  • Gene Synthesis
  • Custom Gene Synthesis
  • Gene Library Synthesis

Segmentation by Application:

  • Research and Development
  • Academic
  • Industrial
  • Diagnosis
  • Therapeutics

Segmentation by End User

  • Biopharmaceutical Companies
  • Academic and Research Institutes
  • Contract Research Organizations

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance

 

Replacement Sheet Market to expand at a steady 4.6% CAGR over the forecast period 2021-2031

According to a recent study by Future Market Insights (FMI), the global replacement sheets market was valued at over US$ 111.9 Mn in 2020 and is expected to exhibit a CAGR of 4.6% over the forecast period.

Sales of replacement sheets stagnated to an extent due to the lockdown restrictions imposed to contain the novel COVID-19 outbreak. However, with a persistent rise in medical procedures related to COVID-19 and other disorders, demand for replacement sheets grew at a 4.3% CAGR in 2020.

Expedited vaccine drives, resumption of production and logistics, and growing preference for retail through online channels are anticipated to positively shape the sales outlook for replacement sheets over the assessment period.

Replacement sheet based patient transfer is one of the crucial methods to change/move patient’s position within healthcare settings. Usage of these sheets ensure that the patient transfer is easy and safer. Moreover, it is the most comfortable method of patient handling for healthcare professionals and the patient.

The geriatric population is most likely to undergo old-age mobility disorders. For example, as per the World Economic Forum, Japan has the title for having around 29% of the largest geriatric population over 65 years out of the total population in mid-2020.

Get a Free Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-13999

Key players operating in the replacement sheets market are investing in research and development top launch products with different technologies. This is indicative of the emergence safe and high-quality products that would minimize patient’s complications, resulting in lucrative growth prospects for regional and global market players.

“Government initiatives adopted to improve the healthcare infrastructure in developing economies, coupled with rising demand for affordable and safer patient repositioning equipment will continue providing tailwinds to replacement sheets sales over the forecast period,” says the FMI analyst. 

Key Takeaways from Market Study

  • The turn sheet segment is expected to gain 1.6X revenue in the market by 2031.
  • Based on end-users, the hospital segment accounted for more than 28% of the market share in 2020.
  • The U.S. is projected to dominate the North America replacement sheets market, capturing 81% of the total market share in 2021.
  • Replacement sheets market in Germany is anticipated to expand at a 5.3% CAGR over the forecast period.
  • The U.K. is expected to emerge as a lucrative market, growing at a 4.3% CAGR through 2031.
  • China will remain an attractive pocket, commanding over nearly half of the East Asia replacement sheets market share in 2021.
  • Sales of replacement sheets in Japan are projected to grow at a 4.0% CAGR, while South Korea holds 19.0% of the East Asia market share currently.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-13999

Competitive Landscape

To gain a competitive edge in the global replacement sheets market,  key market players are investing in strategic collaborations, mergers, and acquisitions. Apart from this, players are focusing on new product developments  to deliver safer and convenient options to ensure patient’s comfortability and safety in both existing and new markets. For instance:

  • Etac, in July 2019, acquired a 70% stake in the US Company, HoverTech International, to strengthen its position in the patient handling segment in the US market.

More Insights into the Replacement Sheets Market Report

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global replacement sheets market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on replacement sheets segment based on product (slide sheet {disposable slide sheets and reusable slide sheets} and turn sheet {disposable turn sheets, reusable turn sheets and air transfer gliding sheets}), end user (hospitals, ambulatory surgery centres, long term care centres, skill nursing facilities, assisted living facilities and others)  across seven major regions.

Have Any Questions Regarding Replacement Sheet Market Report, Ask Our Experts@ https://www.futuremarketinsights.com/ask-question/rep-gb-13999

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Corporate Headquarter
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Website: https://www.futuremarketinsights.com

Headspace Gas Analyzers Market is expected to reach US$ 152.8 Mn by 2031, Exclusive Report By Future Market Insights

According to a recent study by Future Market Insights (FMI), the global headspace gas analyzers (HGA) market is expected to witness high growth during the forecast period. The market is expected to grow from US$ 60.8 Mn in 2020 to over US$ 152.8 Mn by 2031. This reflects a cumulative CAGR of around 8.8% over the forecast period (2021-2031).

Increasing demand for in-process monitoring to keep an eye on various quality parameters of headspace analyzer such as container closure integrity (CCI), oxygen content, and moisture content is expected to push sales of headspace gas analyzers in the near future.

Get a Sample Copy of Report – https://www.futuremarketinsights.com/reports/sample/rep-gb-13979

Recently, regulatory requirements for sterile pharmaceuticals have been increasingly focused on CCI. Numerous new drug items and container systems have been released to the market. In the various stages of the product package life cycle, appropriate level of CCI verification and HGA is advised.

Headspace gas analyzers methods eliminate all the destructive inspections’ limitations, allowing for a targeted, objective, holistic evaluation of the entire production and ensure the product stability.

They also provide sterility throughout the product life cycle, research and validation, normal manufacturing, and the marketed product scenario. As a result, a change in the rules for the use of headspace gas analyzers in the pharmaceutical and other industries is likely to increase the demand for these devices.

Technological advancement and new product launches & approvals have emerged as key growth strategies adopted by the leading players in the headspace gas analyzers market. By adopting these strategies, companies are aiming to expand their regional presence as well as product offerings.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-13979

For instance, in July 2021, the CCI laboratory tester NEO DPX by WILCO AG was honoured with the Good Design Award 2020 in the industrial category by the Chicago Athenaeum Museum of Architecture and Design.

In June 2019, WILCO AG developed an individual system design in six phases for the visual inspection of parenteralia in various packaging materials to achieve the greatest possible reliability of the inspection results.

Such developments not only strengthens the company’s existing portfolio but also help to increase their presence at the regional as well as global level, and helps companies to sustain the increasing competitive pressure.

Key Takeaways from Headspace Gas Analyzers Study

– By product, oxygen headspace analyzers will hold maximum share of more than 45% in 2021.
– In terms of modality, benchtop system of headspace gas analyzers are expected to account for over 60% of the market share in 2021 owing to the extreme stability and accuracy in the inspection of overfilled containers with limited headspace.
– By end user, the hospitals will account for over 40% of the market share in 2021 owing to the rising demand for sterile products and increasing percentage of health problems by unhygienic food packaging.
– North America is expected to hold nearly 40% of global market share in 2021 on the back of rising product adoption, increasing demand for packaging of pharmaceutical products, health consciousness, and increasing disposable incomes

Competitive Landscape

The key market players covered by FMI include WILCO AG, Quantek Instruments Inc., Illinois Instruments Inc., Labthink International Inc., LIGHTHOUSE, GASPOROX AB, Xepics SA, Bonfiglioli Engineering S.r.l.

Get Customization in the Report, Enquire Now @ https://www.futuremarketinsights.com/customization-available/rep-gb-13979

Headspace Gas Analyzers by Category

Product:

  • Oxygen Headspace Analyzers
  • Carbon Dioxide (CO2) Headspace Analyzers
  • Combination Headspace Analyzers
  • Pressure/Moisture Headspace Analyzers

Modality:

  • Benchtop Systems
  • Handheld Headspace Analyzer

End User:

  • Research & Development Facilities
  • Contract Manufacturing Organizations
  • Pharmaceuticals Manufacturing
  • Clinical Trials Agencies

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Home Infusion Therapy Devices Market is expected to total US$ 3.8 Bn by the end of 2031, Says FMI Analyst

According to a recent study by Future Market Insights (FMI), sales of home infusion therapy devices are expected to top US$ 2.0 Bn in 2021, growing at a CAGR of over 6.5% during the forecast period (2021-2031).

Home infusion therapy devices are used for the intravenous administration of medicines. It is commonly prescribed for patients with serious infections and specialized diseases when orally administered medicines are not or comparatively less effective.

Application of home infusion therapy devices is increasing with the rising number of surgeries conducted across the globe. Post-surgery pain management at home can be done with the help of home infusion therapy devices.

Besides this, rising healthcare expenditure and growing awareness regarding the risk and infection amidst the outbreak of COVID-19 is driving the demand of home infusion therapy devices.

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-13974

Key Takeaways from Home Infusion Therapy Devices Market Study

  • By product type, infusion system accessories will hold around 45% of value share globally.
  • Based on the application, antibiotic administration is leading with over 34% of the market share.
  • Home care settings sales will dominate the home infusion therapy devices, with a market share of 65% during the forecast period.
  • By region, the U.S. will dominate the global home infusion therapy devices market with a value share of around 37% during the forecast period.
  • Followed by North America, Europe will be the second-largest leading region, with a value share of 93.2% during the forecast period.
  • India is the dominant country in term of revenue for South Asia Home infusion therapy devices market, accounting for nearly 48% of market share in 2021.
  • China holds leading position in East Asia and is expected to account for nearly 52% of market share.

“Growing prevalence of chronic diseases such as diabetes and cancer in the midst of COVID-19 pandemic and high risk of infection across hospitals encouraged key players to invest in new product launches. This is expected to enable growth in the market in the coming years” says a FMI Analyst.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-13974

Who is Winning?

Key players are focusing on new product launches and approvals. Other growth strategies adopted by leading players include, agreements, and collaborations among key manufacturers. By focusing on these strategies, key players are expanding their geographic presence and strengthening their existing product portfolio.

For instance,

  • In June 2019, Baxter International Inc. announced that Myxredlin that is the first and only ready-to-use insulin for IV infusion get the US FDA approval.
  • In Jan 2019, Fresenius Kabi AG launched two colourful bags via white spiral cables to supply the nutrient solution for parenteral nutrition.
  • In April 2017, B. Braun Melsungen AG announced the launch of home infusion therapy App named Easypump® for healthcare professionals and patients.

The key market players profiled by FMI include Becton, Diciknson & Company, B.Braun Melsungen AG, Baxter International, Fresenius Kabi, Terumo Corporation, ICU Medical, Nipro Corporation, Smiths Medical, Micrel Medical Devices SA, Moog Inc., JMS Co.Ltd., Intera Oncology, and Others Top-up.

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-13974

Home Infusion Therapy Devices Market by Category

By Product Type:

  • Disposable Elastomeric Pumps
  • Insulin Pumps
  • PCA Pumps
  • Electronic Ambulatory Pumps
  • Infusion System Accessories

By Applications:

  • Enteral Nutrition
  • Parenteral Nutrition
  • Chemotherapy
  • Antibiotic Administration
  • Others

By End User:

  • Home Care Settings
  • Long Term Care Centers

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Needle-Free Injectors Market sales are expected to reach US$ 12.3 Bn in 2021, surging at 11.4% CAGR during the forecast period 2021-2031

ESOMAR-certified market research firm Future Market Insights (FMI) has forecast the Needle-Free Injectors Market to exhibit a year-on-year (YoY) growth of 11.9% in 2021, reaching a valuation of around US$ 12.3 Bn by the end of the year.

Owing to the increasing healthcare expenditure and rising prevalence of chronic diseases, the demand for needle-free injectors is set to rise at a CAGR of around 11.4% between 2021 and 2031, surpassing a valuation of around US$ 36.3 Bn by the end of 2031.

Increasing cases of needle prick injuries, high prevalence of chronic diseases, growing demand for self-injection devices, and various advantages associated with needle-free injection technology are some of the factors driving the needle-free injectors market. Needle-free injectors also are ideal for people who suffer from needle phobia.

As per the Centers for Diseases Control and Prevention (CDC), hospital-based healthcare personnel experience around 385,000 needle-stick/sharps injuries each year (2015). Needle stick injuries can lead to serious or potentially fatal infections due to potential exposure to blood borne pathogens such as hepatitis B virus, hepatitis C virus, and Human immunodeficiency virus (HIV).

Request a report sample to gain compressive insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-13960

Initiatives launched by organizations such as Occupational Safety and Health Administration (OSHA), National Institution for Occupational Safety and Health (NIOSH), and Food and Drug Administration (FDA) to reduce needle stick injuries and the subsequent risk of blood borne pathogen transmission are positively impacting the needle-free injectors market.

Sales of needle-free injectors skyrocketed during the COVID-19 pandemic. Many pharmaceutical companies started administrating SARS-CoV-2 vaccine by using needle-free injection systems. For instance, in September 2021, Pharmajet, announced that its partner, Scancell has selected its devices to administer two SARS-CoV-2 DNA vaccine candidate, SCOV1 and SCOV2. The vaccines will be exclusively administered using the Pharmajet Tropis and Pharmajet Stratis Needle-free injection systems.

Growing popularity of needle-free injectors in cosmetic industry will further accelerate growth in the market. As per FMI, the cosmetic segment is set to witness maximum growth at a CAGR of 12.6% during the forecast period.

North America will continue to dominate the needle-free injectors market with around 42% of total market share. This can be attributed to the increasing investment in research and development, presence of leading market players, rise in diseases like diabetes, and growing preference for noninvasive procedures.

“Rising demand for self-injection drugs and increasing health consciousness among people will accelerate the growth of needle-free injectors market during the assessment period. Besides this, new product launches and approvals will play a key role strengthening footprint of various market players,” says the FMI analyst.

Get Customized report as per your requirement – https://www.futuremarketinsights.com/customization-available/rep-gb-13960 

Key Takeaways from Needle-Free Injectors Market Survey

  • The U.S. will continue to dominate the North America needle-free injectors market with over 94% share in 2021. The robust growth can be attributed to the rising prevalence of chronic diseases and growing preferences for non-invasive procedures.
  • With increasing expenditure in healthcare, Germany is expected to account for 29.4% share in the European market during the forecast period.
  • Japan is projected to hold over 34% share in the East Asia market during the assessment period.
  • With around 46.8% share in the East Asia market, China will exhibit a CAGR of 12% between 2021 and 2031.
  • Based on load, the liquid injections segment will hold around 88% share of the global market.
  • In terms of technology, spring loaded jet injector is dominating the market with over 47.1% of the market share.
  • By application, drug delivery segment is expected to hold dominant share in the global market, accounting for around 65% of the revenue share in 2021.

Competitive Landscape

Key players operating in the needle-free injectors market are focusing on expanding their product portfolio by investing in research & development activities. They have adopted various organic and inorganic growth strategies such as mergers and acquisitions, new product launches, partnerships and collaborations to strengthen their global footprint.

Some of the prominent players operating in the needle-free injectors market profiled by FMI are:

  • Gerresheimer AG
  • Pfizer Inc.
  • Antares Pharma
  • CSL Limited (Seqirus UK Limited)
  • Crossject
  • Portal Instruments
  • Ferring Pharmaceuticals
  • PharmaJet Inc.
  • PenJet Corporation

More Insights on the Global Needle-Free Injectors Sales Outlook

FMI provides an unbiased analysis of needle-free injectors market, presenting historical demand data (2016-2020) and forecast statistics for the period from 2021-2031. The study divulges compelling insights on the global demand for needle-free injectors with a detailed segmentation on the basis of:

Load:

  • Liquid Injections
  • Powder Injections
  • Projectile Injections

Technology:

  • Spring-loaded jet injector
  • Battery-powered jet injector
  • Gas-powered jet injector

Delivery Site:

  • Intra dermal injectors
  • Intramuscular injectors
  • Subcutaneous injectors

Application:

  • Drug Delivery
  • Vaccines
  • Cosmetic
  • Others

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Discover more about Needle-Free Injectors Market with figures and data tables, along with the table of contents. You will also find detailed market segmentation on https://www.futuremarketinsights.com/ask-question/rep-gb-13960

Key Questions Covered in the Needle-Free Injectors Sales Outlook Report

  • The report offers insight into needle-free injectors demand outlook for 2021-2031
  • The market study also highlights projected sales growth for needle-free injectors market between 2021 and 2031
  • Needle-free injectors market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
  • Needle-free injectors market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others